Basic Information
| LncRNA/CircRNA Name | AL163952.1 |
| Synonyms | NA |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
| Regulatory Mechanism | Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Information of Cancer
| Cancer Name | tongue squamous cell carcinoma |
| ICD-0-3 | C02 |
| Methods | RNA-seq |
| Sample | TSCC tissues |
| Expression Pattern | differentially expressed |
| Function Description | we identified ten lncRNAs (PART1, LINC00261,AL163952.1, C2orf48, FAM87A, LINC00052, LINC00472, STEAP3-AS1, TSPEAR-AS1 and ERVH48-1) as novel, potential prognostic biomarkers and therapeutic targets for TSCC. |
| Pubmed ID | 30755833 |
| Year | 2019 |
| Title | Comprehensive analysis of lncRNA-associated competing endogenous RNA network in tongue squamous cell carcinoma. |
External Links
| Links for AL163952.1 | GenBank HGNC Noncode |
| Links for tongue squamous cell carcinoma | Omim Cosmic |